Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Free Radical Biology & Medicine
|
June 19, 2012
Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease
Almas Siddiqui, Shankar J Chinta, Jyothi K Mallajosyula, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 18, 2015
Mitochondrial Quality Control via the PGC1α-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin
Almas Siddiqui, Dipa Bhaumik, Shankar J Chinta, et al.
Brain Research
|
December 3, 2014
Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model
Christopher A Lieu, Colleen M Dewey, Shankar J Chinta, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 21, 2007
Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration
Shankar J Chinta, M J Kumar, Michael Hsu, et al.
Plos One
|
February 21, 2008
MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology
Jyothi K Mallajosyula, Deepinder Kaur, Shankar J Chinta, et al.
Cell Reports
|
February 2, 2018
Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson's Disease
Shankar J Chinta, Georgia Woods, Marco Demaria, et al.
Free Radical Biology & Medicine
|
June 20, 2012
Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease
Almas Siddiqui, Sulay Rivera-Sánchez, María del R Castro, et al.
Geroscience
|
August 26, 2022
Potassium-chelating drug sodium polystyrene sulfonate enhances lysosomal function and suppresses proteotoxicity
Cyrene Arputhasamy, Anna C Foulger, Mark Lucanic, et al.
Aging Cell
|
April 5, 2021
Trimethylamine modulates dauer formation, neurodegeneration, and lifespan through tyra-3/daf-11 signaling in Caenorhabditis elegans
Amit Khanna, Durai Sellegounder, Jitendra Kumar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 24, 2017
Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease
Edilio Borroni, Bernd Bohrmann, Fiona Grueninger, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Free Radical Biology & Medicine
|
June 19, 2012
Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease
Almas Siddiqui, Shankar J Chinta, Jyothi K Mallajosyula, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 18, 2015
Mitochondrial Quality Control via the PGC1α-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin
Almas Siddiqui, Dipa Bhaumik, Shankar J Chinta, et al.
Brain Research
|
December 3, 2014
Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model
Christopher A Lieu, Colleen M Dewey, Shankar J Chinta, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 21, 2007
Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration
Shankar J Chinta, M J Kumar, Michael Hsu, et al.
Plos One
|
February 21, 2008
MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology
Jyothi K Mallajosyula, Deepinder Kaur, Shankar J Chinta, et al.
Cell Reports
|
February 2, 2018
Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson's Disease
Shankar J Chinta, Georgia Woods, Marco Demaria, et al.
Free Radical Biology & Medicine
|
June 20, 2012
Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease
Almas Siddiqui, Sulay Rivera-Sánchez, María del R Castro, et al.
Geroscience
|
August 26, 2022
Potassium-chelating drug sodium polystyrene sulfonate enhances lysosomal function and suppresses proteotoxicity
Cyrene Arputhasamy, Anna C Foulger, Mark Lucanic, et al.
Aging Cell
|
April 5, 2021
Trimethylamine modulates dauer formation, neurodegeneration, and lifespan through tyra-3/daf-11 signaling in Caenorhabditis elegans
Amit Khanna, Durai Sellegounder, Jitendra Kumar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 24, 2017
Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease
Edilio Borroni, Bernd Bohrmann, Fiona Grueninger, et al.
Page
of 4